Keeping you informed and equipped regarding all financial matters

We have assembled a selection of information, market commentary and related links to help you gain a greater understanding of all things financial. Bookmark this page and check back for regular updates.

Weekly Market Guide
1/22/2021
Review the latest portfolio strategy commentary from Mike Gibbs, managing director of Equity Portfolio & Technical Strategy.
Markets & Investing
Will This Be Another Strong Year for Stocks?
1/21/2021
Surprisingly, U.S. equities notched strong annual growth in 2020. Will domestic and global financial markets push even higher in 2021?
Markets & Investing
Listen
View
2021 Outlook: A Return to Normal? [INFOGRAPHIC]
1/20/2021
Review this visual summary of the Raymond James Investment Strategy Committee’s outlook for investors in the coming year.
Markets & Investing
Have You Hired the Right Tax Accountant?
1/20/2021
Five signs you’ve chosen the right accountant; two signs that suggest proceeding with caution.
Tax Planning
So Many Variables
1/19/2021
Doug Drabik discusses fixed income market conditions and offers insight for bond investors.
Markets & Investing
Read
The Inflation Outlook
1/15/2021
Chief Economist Scott Brown discusses current economic conditions.
Economy & Policy
Read
Weekly Investment Strategy
1/15/2021
Review the latest Weekly Headings by CIO Larry Adam.
Markets & Investing
Read
Weekly Market Guide
1/15/2021
Review the latest portfolio strategy commentary from Mike Gibbs, managing director of Equity Portfolio & Technical Strategy.
Markets & Investing
Weekly Market Snapshot
1/15/2021
Chief Economist Scott Brown discusses the latest market data.
Economy & Policy
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
Load more
Load more

Raymond James financial advisors may only conduct business with residents of the states and/or jurisdictions for which they are properly registered. Therefore, a response to a request for information may be delayed. Please note that not all of the investments and services mentioned are available in every state. Investors outside of the United States are subject to securities and tax regulations within their applicable jurisdictions that are not addressed on this site. Contact your local Raymond James office for information and availability.

Mainspring Wealth Advisors, LLC is an investment adviser registered in the State of Washington but does not provide any services or offer any investment advice. Investment advisory services are offered through Raymond James Financial Services Advisors, Inc. and securities are offered through Raymond James Financial Services, Inc., member FINRA/SIPC. Mainspring Wealth Advisors, LLC is not a registered broker/dealer and is independent of Raymond James Financial Services. The adviser may not transact business in states it is not appropriately registered, excluded or exempted from registration. Individualized responses to persons that involve either the effecting of transaction in securities, or rendering personalized investment advice for compensation, will not made without registration or exemption.

© 2021 Securities offered through Raymond James Financial Services, Inc., member FINRA / SIPC    |   Legal Disclosures   |   Privacy, Security & Account Protection   |   Terms of Use